胃バルーン処置の世界市場-2023-2030

市場概要

胃バルーン処置の世界市場規模は、2023年に4945万米ドルに達すると推定され、予測期間（2023～2030年）にCAGR12.4％で成長するとされています。

胃バルーン療法は、内視鏡的胃内バルーンとも呼ばれ、患者の胃に1～3個のシリコンバルーンを数ヶ月間挿入し、過剰体重を30％程度減少させ、それによって患者の健康状態を改善する方法です。

市場力学

胃バルーン手術の世界市場を牽引する主な要因は、肥満が主な原因となる2型糖尿病の発生率の増加による胃バルーン手術の需要増加、フィットネスや構造に関する意識の高まり、世界の肥満人口の増加、啓発活動の高まり、新規製品の発売につながる技術の進歩などです。

フィットネスや体質に対する意識の高まりや、世界中で肥満人口が増加していることが、新製品の開発につながり、市場の成長を促進するものと期待されています。

胃バルーン手術市場は、フィットネスと構造に関する意識の高まり、技術の進歩の高まり、老人人口の増加、研究開発投資の急増、主に肥満に起因する2型糖尿病の症例数の増加、新興市場の医療インフラの改善とともに最新技術を用いた新規製品の改善によって牽引されています。

胃バルーンは、体重を減らすために広く使用されています。これらのデバイスの採用が増加しているため、政府の取り組みや資金が増加しています。これらの資金は、シングル、デュアル、トリプルの胃バルーンなどの胃バルーン製品の生産を支援します。これらの胃バルーン市場は、肥満に苦しむ人々の数が増加したため、世界中で増加しています。さらに、主要メーカーが技術的に高度な製品を提供していることも、市場の成長に重要な役割を果たすと予想されます。

2022年5月26日、医師主導のメタボリックヘルスおよび減量ソリューション企業であるリシェイプライフサイエンスは、仮想減量指導のための医師主導、全国、遠隔健康ソリューションを手配するために、仮想ケアフルスタック配信サービスプロバイダーのOpenLoopと合意したことを発表しました。

胃バルーンを使用することによるリスクや安全性の懸念は、市場の成長を妨げると予想されます。

しかし、胃バルーン設置の手順に利用されるシリコンバルーンの承認のための厳格な規則や規制は、胃バルーン手順市場の成長を阻害する主要な要因です。また、これらの処置の高コストも制限要因となっています。

これらの胃バルーンやカテーテルの使用に関連するリスクと安全性の懸念は、成長を阻害する可能性が高いです。生理食塩水またはガスのいずれかで満たされているこれらの胃のバルーンに関連する高リスクは、デバイスの除去のための手術を必要とする閉塞を引き起こす可能性があります。その他のリスクとしては、急性膵炎、過膨張、胃壁の潰瘍などがあります。

COVID-19影響度分析

パンデミックは、世界の財務的な期待、オペレーション、危機対応戦略にマイナスの影響を及ぼしています。COVID-19の発生は、ヘルスケア産業に深刻な影響を及ぼしています。胃バルーン処置市場は、COVIDのために莫大な損失を経験しました。主要メーカーは、様々な調査や臨床試験を開始しました。様々な取り組み、製品の発売、コラボレーション、合併が世界中で行われ、市場の成長を後押ししています。例えば、2022年10月31日、医師主導の代謝健康・減量ソリューション企業であるReShape Lifesciencesは、国際肥満・代謝疾患外科連盟（IFSO）と米国代謝・肥満外科学会（ASMBS）が、ラップバンドを含む代謝・肥満外科の更新した新規ガイドラインを発行したと発表しています。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場影響要因
  • 促進要因
    • フィットネスと体質に対する意識の高まり
    • 肥満人口の増加
  • 抑制要因
    • 胃バルーン使用時の安全性に関する懸念
    • 高いコスト
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• プライシング分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 製品タイプ別

• シングル胃バルーン
• デュアルガストロニックバルーン
• トリプルガストロニックバルーン

第8章 術式別

• 内視鏡的
• 非内視鏡的

第9章 充填物別

• 生理食塩水充填胃バルーン
• ガス充填胃バルーン

第10章 容量別

• 調節可能な胃部バルーン
• 非調整型胃部バルーン

第11章 エンドユーザー別

• 病院
• 外来手術センター
• 診療所

第12章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第13章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク
• 注目の主要企業リスト

第14章 企業プロファイル

• Apollo Endosurgery Inc.
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• ReShape Lifesciences, Inc.
• LEXEL S.R.L.
• Medispar c.v.b.a.
• Allurion
• Helioscopie Medical Implants
• Districlass Medical
• ENDALIS
• Accel Medical
• Silimed, Inc.

第15章 胃バルーン処置の世界市場-DataM

Market Overview

The global gastric balloon procedures market size was valued at US$ 49.45 million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 12.4% during the forecast period (2023-2030).

Gastric balloon procedures also called an endoscopic intragastric balloon, is the procedure of inserting 1 to 3 silicon balloons in the stomach of the patient for a few months so that they lose around 30% of excess weight, thereby improving the health condition of the patient.

Market Dynamics

The major factors driving the global gastric balloon procedures market are the rising demand for gastric balloon procedures owing to increasing incidences of type-2diabetes which is mainly caused due to obesity, increasing consciousness on fitness and structure, growing obese population across the globe,, surging awareness initiatives, advancements in technologies leading to novel product launches.

The increasing consciousness on fitness and structure and growing obese population across the globe leading to the development of novel products are expected to drive the market's growth.

The gastric balloon procedures market is driven by increasing consciousness on fitness and structure, rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of type-2 diabetes cases which is mainly caused due to obesity and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The gastric balloon procedures are used widely for weight loss. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce gastric balloon products such as single, dual and triple gastric balloons. The market for these gastric balloons is increasing worldwide due to the enhanced number of people suffering from obesity. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these gastric balloon procedures medications contribute to the market's growth. in May 26, 2022, ReShape Lifesciences, a physician-led metabolic health and weight loss solutions company announced its agreement with OpenLoop, virtual care full-stack delivery services provider, to arrange a physician-led, nationwide, telehealth solution for virtual weight loss coaching.

Risks and safety concerns associated with the use of these gastric balloons are expected to hamper the market's growth.

However strict rules and regulations for the approval of the silicone balloons utilized for procedure of gastric balloon placement is the major factor hindering the growth of the gastric balloon procedures market. High costs of these procedures is also a limiting factor.

The risks and safety concerns associated with the use of these gastric balloons or catheters are likely to hinder the growth. High risk related to these gastric balloons that are filled with either saline or gas can cause a blockage which requires surgery for the removal of device. Other risks are acute pancreatitis, over-inflation and ulcers in the stomach wall.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The gastric balloon procedures market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in October 31, 2022, ReShape Lifesciences, a physician-led metabolic health and weight loss solutions company announced that the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the American Society for Metabolic and Bariatric Surgery (ASMBS) have issued novel guidelines that have been updated for Metabolic and Bariatric Surgery which include the Lap-Band.

Segment Analysis

The single gastric balloon segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The single gastric balloon segment is the highest market holder in the global gastric balloon procedures market. The global gastric balloon procedures market is segmented based on product type as single gastric balloon, dual gastric balloon and triple gastric balloon. The single gastric balloon segment is the largest market shareholder due to its increasing number of procedures utilizing single gastric ballons globally, increasing technological advancements and novel product launches.

Single gastric balloon is the most commonly used balloon for gastric balloon procedures which is easy to insert as this one time procedure where the doctor will place the catheter inside the stomach and then fill the balloon with either gas or saline water so the person may feel full after eating small amount of food. This balloon will then be removed after 6 months of placement. This whole procedure is done under direct supervision of endoscopy. The procedure involving single gastric balloon is easy to perform.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market's growth. For instance, in November 21, 2022, Apollo Endosurgery, Inc., a minimally invasive medical devices provider for bariatric and gastrointestinal procedures, announced about its successful transition under the European Medical Device Regulation (MDR) of legacy products including for the BIB, OverStitch Systems and Orbera 365 intragastric balloons to CE Mark. The novel certificates were issued by British Standards Institute and are valid for five years.

Geographical Analysis

North America holds the largest market share in the global gastric balloon procedures market.

North America dominates the global gastric balloon procedures market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of gastric balloon procedures such as endoscopic or non-endoscopic like swallowing for weight loss, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the gastric balloon procedures market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in November 29, 2022, Apollo Endosurgery, Inc., a minimally invasive medical device provider company for bariatric and gastrointestinal procedures, announced about entering into an acquisition merger agreement with Boston Scientific Corporation, a medical technology provider company.

Competitive Landscape

The gastric balloon procedures market is moderately competitive with local and global companies' presence. Apollo Endosurgery Inc., ReShape Lifesciences, Inc., LEXEL S.R.L., Medispar C.V.B.A, Allurion, Helioscopie Medical Implants, Districlass Medical, ENDALIS, Accel Medical, Silimed, Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in June 16, 2021, ReShape Lifesciences Inc., a weight-loss solutions provider announced its completion of the announced merger with Obalon Therapeutics. Obalon's name is changed to ReShape Lifesciences Inc. and company's combined common stock will initiate trading under the ticker symbol "RSLS".

ReShape Lifesciences, Inc.

Overview: ReShape Lifesciences is a metabolic health and weight loss-solutions provider company, providing an integrated portfolio of products and services that treat and manage obesity and metabolic disorders.

Product Portfolio:

Obalon Balloon System: It is the first and only gas-filled, swallowable, FDA-approved balloon system specially developed for weight-loss.

The global gastric balloon procedures market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing consciousness on fitness and structure
    • 4.1.1.2. Growing obese population
  • 4.1.2. Restraints:
    • 4.1.2.1. Safety concerns regarding the use of gastric balloons
    • 4.1.2.2. High cost
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1 Porter's Five Forces Analysis
• 5.2 Supply Chain Analysis
• 5.3 Pricing Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Single Gastric Balloon*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Dual Gastric Balloon
• 7.4. Triple Gastric Balloon

8. By Procedure

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
  • 8.1.2. Market Attractiveness Index, By Placement
• 8.2. Endoscopic *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Non-Endoscopic

9. By Filling

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
  • 9.1.2. Market Attractiveness Index, By Filling
• 9.2. Saline-Filled Gastric Balloon*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Gas-Filled Gastric Balloon

10. By Volume

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
  • 10.1.2. Market Attractiveness Index, By Volume
• 10.2. Adjustable Gastric Balloon *
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 10.3. Non-Adjustable Gastric Balloon

11. By End-User

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.1.2. Market Attractiveness Index, By End-User
• 11.2. Hospitals *
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 11.3. Ambulatory Surgical Centers
• 11.4. Clinics

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
  • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
  • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
  • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.2.8.1. U.S.
    • 12.2.8.2. Canada
    • 12.2.8.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
  • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
  • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
  • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.3.8.1. Germany
    • 12.3.8.2. U.K.
    • 12.3.8.3. France
    • 12.3.8.4. Italy
    • 12.3.8.5. Spain
    • 12.3.8.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
  • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
  • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
  • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.4.8.1. Brazil
    • 12.4.8.2. Argentina
    • 12.4.8.3. Rest of South America
• 12.5. Asia Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
  • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
  • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
  • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.5.8.1. China
    • 12.5.8.2. India
    • 12.5.8.3. Japan
    • 12.5.8.4. Australia
    • 12.5.8.5. Rest of Asia Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
  • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
  • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
  • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

• 13.1. Key Developments and Strategies
• 13.2. Company Share Analysis
• 13.3. Products Benchmarking
• 13.4. List of Key Companies to Watch

14. Company Profiles

• 14.1. Apollo Endosurgery Inc. *
  • 14.1.1. Company Overview
  • 14.1.2. Product Portfolio and Description
  • 14.1.3. Key Highlights
  • 14.1.4. Financial Overview
• 14.2. ReShape Lifesciences, Inc.
• 14.3. LEXEL S.R.L.
• 14.4. Medispar c.v.b.a.
• 14.5. Allurion
• 14.6. Helioscopie Medical Implants
• 14.7. Districlass Medical
• 14.8. ENDALIS
• 14.9. Accel Medical
• 14.10. Silimed, Inc.

LIST NOT EXHAUSTIVE

15. Global Gastric Balloon Procedures Market - DataM

• 15.1. Appendix
• 15.2. About Us and Medications
• 15.3. Contact Us